Recent transactions
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Oct 23, 2026 | Parker Geoffrey M. | CFO | S Sale | — | $1.34 | $49K | filing |
| Aug 25, 2026 | Douglas Earl Martin | SVP, GC | S Sale | — | $2.12 | $63K | filing |
ALLOGENE THERAPEUTIC (ALLO) insider trades
ALLOGENE THERAPEUTIC (ALLO) insider trading activity (SEC Form 4). Over the trailing 90 days, ALLO insiders filed 0 purchases totalling $0 and 2 sales totalling $112K — net SELLING of $112K. Most recent filing: Oct 23, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
2
$112K
Net (90d)
-$112K
net selling
Most recent
Oct 23, 2026